ORLANDO — While there will always be points of friction in the market, unmet needs in ophthalmology will ultimately yield innovation, according to a speaker at Eyecelerator@AAO.
In an ophthalmic market overview, Kristen Harmon Ingenito, MBA, CEO of Market Scope, valued the ophthalmic market at $48.7 billion in 2024, with an expected combined annual growth rate of 4.5% through 2029.
“Our fastest growing segment continues to be the glaucoma surgical device space, and we’re also seeing a lot of growth in IOLs,” Ingenito said. “Retina pharmaceuticals continues to be our slowest growing market, but